MAPK1 and cancer: Nikolaev et al. identified a KRAS mutation in cerebral AVM lesions that coincided with dysregulation of the MAPK-extracellular-signal-regulated kinase (MAPK-ERK) pathway, which is also associated with the development of a number of types of cancer [62].